ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced products on display, sponsorship of several percutaneous coronary intervention (PCI) optimization symposia and reporting of results from an economic analysis during a late breaking trial session at the Paris Course on Revascularization (EuroPCR) 2011. The focus on clinical research and new product development reflects the company’s commitment to provide physicians with innovative solutions that demonstrate a tangible benefit to patients and society.
